COVID-19 and spontaneous pneumothorax: a survival analysis.
COVID-19
CT scan
Pneumothorax
Journal
Journal of cardiothoracic surgery
ISSN: 1749-8090
Titre abrégé: J Cardiothorac Surg
Pays: England
ID NLM: 101265113
Informations de publication
Date de publication:
04 Jul 2023
04 Jul 2023
Historique:
received:
20
01
2023
accepted:
29
06
2023
medline:
6
7
2023
pubmed:
5
7
2023
entrez:
4
7
2023
Statut:
epublish
Résumé
COVID-19 Patients may be at risk for involving with spontaneous pneumothorax. However, clinical data are lacking in this regard. In this study, we aimed to investigate the demographic, clinical, and radiological characteristics and survival predictors in COVID-19 patients with pneumothorax. This is a retrospectivestudy conducted on COVID-19 patients with pneumothorax that had been hospitalized at hospital. l from December 2021 to March 2022. The chest computed tomography (CT) scan of all patients was reviewed by an experienced pulmonologist in search of pulmonary pneumothorax. Survival analysis was conducted to identify the predictors of survival in patients with COVID-19 and pneumothorax. A total of 67 patients with COVID-19 and pneumothorax were identified. Of these, 40.7% were located in the left lung, 40.7% were in the right lung, and 18.6% were found bilaterally. The most common symptoms in the patient with pneumothorax were dyspnea (65.7%), increased cough severity (53.7%), chest pain (25.4%), and hemoptysis (16.4%). The frequency of pulmonary left and right bullae, pleural effusion, andfungus ball were 22.4%, 22.4%, 22.4%, and 7.5%, respectively. Pneumothorax was managed with chest drain (80.6%), chest drain and surgery (6%), and conservatively (13.4%). The 50-day mortality rate was 52.2% (35 patients). The average survival time for deceased patients was 10.06 (2.17) days. Our results demonstrated that those with pleural effusion or pulmonary bullae have a lower survival rate. Further studies are required to investigate the incidence and causality relation between COVID-19 and pneumothorax.
Identifiants
pubmed: 37403072
doi: 10.1186/s13019-023-02331-0
pii: 10.1186/s13019-023-02331-0
pmc: PMC10318738
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
211Informations de copyright
© 2023. The Author(s).
Références
Clin Radiol. 2002 Jan;57(1):8-17
pubmed: 11798197
Clin Med (Lond). 2020 Jul;20(4):e60-e61
pubmed: 32457134
Thorax. 2010 Aug;65 Suppl 2:ii18-31
pubmed: 20696690
Ann Thorac Surg. 2020 Nov;110(5):e413-e415
pubmed: 32353441
S D Med. 2020 Jul;73(7):312-317
pubmed: 32805781
Medicine (Baltimore). 2020 May;99(18):e20175
pubmed: 32358406
Korean J Thorac Cardiovasc Surg. 2016 Aug;49(4):287-91
pubmed: 27525238
Interact Cardiovasc Thorac Surg. 2022 Jun 1;34(6):1002-1010
pubmed: 34661670
Lancet Respir Med. 2020 Apr;8(4):420-422
pubmed: 32085846
Radiology. 2004 Feb;230(2):339-46
pubmed: 14752179
AJR Am J Roentgenol. 2015 Sep;205(3):W267-74
pubmed: 26102309
Heart Lung. 2021 Jan - Feb;50(1):37-43
pubmed: 33138976
IDCases. 2020 Jun 17;21:e00868
pubmed: 32596131
Clin Imaging. 2020 Nov;67:207-213
pubmed: 32871424
Int J Antimicrob Agents. 2020 Mar;55(3):105924
pubmed: 32081636
Trauma Surg Acute Care Open. 2020 Apr 30;5(1):e000498
pubmed: 32411822
Radiographics. 2020 Nov-Dec;40(7):1848-1865
pubmed: 33095680
Emerg Radiol. 2020 Dec;27(6):727-730
pubmed: 32524296
Br J Anaesth. 2020 Jul;125(1):e28-e37
pubmed: 32312571
J Intern Med. 2021 Feb;289(2):147-161
pubmed: 32696489
JAMA. 2020 Jun 23;323(24):2518-2520
pubmed: 32437497
J Med Virol. 2020 Nov;92(11):2511-2515
pubmed: 32293741
Korean J Radiol. 2020 May;21(5):541-544
pubmed: 32207255
Radiol Med. 2020 Jul;125(7):636-646
pubmed: 32500509
Radiology. 2020 Aug;296(2):E32-E40
pubmed: 32101510
Eur Radiol. 2021 Nov;31(11):8141-8146
pubmed: 33871709
AJR Am J Roentgenol. 2020 Jul;215(1):87-93
pubmed: 32174129
Lancet. 2020 Feb 15;395(10223):507-513
pubmed: 32007143
Einstein (Sao Paulo). 2021 Nov 05;19:eAO6363
pubmed: 34755810
World J Clin Cases. 2020 Aug 6;8(15):3177-3187
pubmed: 32874972